Post-marketing safety monitoring of Shenqifuzheng injection
10.13699/j.cnki.1001-6821.2015.18.025
- VernacularTitle:参芪扶正注射液上市后安全性的监测研究
- Author:
Ying ZHAO
1
;
Pu HUANG
;
Chen SHI
;
San-Lan WU
;
Li-Xiu YU
;
Chun-Sheng CHEN
Author Information
1. 华中科技大学 同济医学院 附属协和医院 药剂科
- Keywords:
Shenqifuzheng injection;
hospital centralized monitoring;
safety reassessment;
clinical use;
adverse drug reaction
- From:
The Chinese Journal of Clinical Pharmacology
2015;(18):1881-1882
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the clinical use and occurrence of ad-verse reactions of Shenqifuzheng injection , and to provide reference for rational drug use in the clinic .Methods Based on the method of the real world study , the clinical data of Shenqifuzheng injection in our hos-pital was tracked and analyzed .Results A total of 438 inpatients were enrolled in this study.Shenqifuzheng injection was used accorded with the drug instruction mostly . The incidence of adverse drug reaction ( ADR ) of Shenqifuzheng injection was 0.23%, which showed good safety.Conclusion The application of Shenqifuzheng injection was rational and safe in our hospital .The real world study is effective for clinical reasearch of medicine .
